|
PPIL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62836411021772E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.38222766565832E-13 |
| Normal-vs-Stage2 |
2.135300E-03 |
| Normal-vs-Stage3 |
1.03361763592602E-13 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.274000E-02 |
| Stage1-vs-Stage3 |
7.432500E-02 |
| Stage1-vs-Stage4 |
1.52181999999446E-05 |
| Stage2-vs-Stage3 |
3.338600E-03 |
| Stage2-vs-Stage4 |
1.83859999999259E-05 |
| Stage3-vs-Stage4 |
1.989900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
7.83189999999934E-05 |
| Normal-vs-Asian |
2.271738352988E-12 |
| Caucasian-vs-AfricanAmerican |
4.055000E-01 |
| Caucasian-vs-Asian |
3.065600E-01 |
| AfricanAmerican-vs-Asian |
2.544400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.02210495412214E-11 |
| Normal-vs-Female |
1.6295853555448E-12 |
| Male-vs-Female |
5.679000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(41-60Yrs) |
1.76814118901802E-12 |
| Normal-vs-Age(61-80Yrs) |
6.61860000139569E-08 |
| Normal-vs-Age(81-100Yrs) |
1.383890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.547800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.919000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.994200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.673000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.711200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.528000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.26109999998292E-06 |
| Classical-VS-Follicular |
1.796230E-04 |
| Classical-VS-Other |
2.721200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.64759983434237E-10 |
| Tall-VS-Other |
6.845000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.378100E-02 |
| Follicular-VS-Normal |
7.815300E-04 |
| Other-VS-Normal |
6.10699999999964E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03880000157375E-08 |
| Normal-vs-N1 |
4.44089209850063E-16 |
| N0-vs-N1 |
1.8084999999779E-06 |
|
|
